Da Xu

LRP5 competes for SPOP binding to enhance tumorigenesis mediated by Daxx and PD-L1 in prostate cancer.

Si-shun Gan, Xiuwu Pan, Xiangmin Zhang, 2023, Experimental cell research.

Integrated analysis of tertiary lymphoid structures and immune infiltration in ccRCC microenvironment revealed their clinical significances: a multicenter cohort study

Wen-jin Chen, Jia-xin Chen, Wei-jie Chen, 2024, Journal for ImmunoTherapy of Cancer.

Preoperative neoadjuvant targeted therapy remodels intra-tumoral heterogeneity of clear-cell renal cell carcinoma and ferroptosis inhibition induces resistance progression.

Si-shun Gan, Wen-jin Chen, Jia-xin Chen, 2024, Cancer letters.